mpn transformation and treatment options
Published 2 years ago • 529 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
2:34
update on the management of patients with mpns in transformation
-
0:56
the role of navtemadlin in the mpn treatment landscape
-
2:55
mpns: a changing treatment landscape
-
1:31
pevaz update: pevonedistat & azacitidine in r/r mds and mds/mpn after dnmti failure
-
2:28
how to approach the treatment of younger patients with mpn
-
2:43
the management of advanced phase mpns
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
9:25
mgus diagnosis: a step-by-step approach
-
0:59
investigating jak2v617f as a therapeutic target in mpns
-
3:49
factors influencing mpn progression
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:18
evolving treatment options in ndmm: transplant-eligible and transplant-ineligible patients
-
1:14
modern prognostication in mpns: improving risk stratification & treatment approaches
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
6:00
covid-19 and mpn updates
-
5:31
how will ai tools and llms help to transform medicine and cancer care in the future?
-
1:14
an overview of the current and future treatment landscape for mpns
-
2:09
heart transplantation in attr amyloidosis